PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.74%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-1.10%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
3.79%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
8.77%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
-11.07%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.54%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-15.38%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.62%
Share change of 0.62% while ADI is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.04%
Diluted share change of 1.04% while ADI is zero. Bruce Berkowitz might see a minor difference that could widen over time.
0.42%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-53.76%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-57.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
183.96%
10Y revenue/share CAGR above 1.5x ADI's 101.11%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
23.39%
5Y revenue/share CAGR above 1.5x ADI's 6.58%. David Dodd would look for consistent product or market expansions fueling outperformance.
66.90%
3Y revenue/share CAGR above 1.5x ADI's 32.97%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
152.15%
10Y OCF/share CAGR 1.25-1.5x ADI's 135.41%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
2.25%
Below 50% of ADI's 17.38%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
99.54%
3Y OCF/share CAGR under 50% of ADI's 250.62%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1259.23%
Net income/share CAGR above 1.5x ADI's 588.43% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-35.21%
Negative 5Y net income/share CAGR while ADI is 3.46%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
1638.85%
3Y net income/share CAGR above 1.5x ADI's 446.28%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
55.33%
10Y equity/share CAGR at 75-90% of ADI's 62.53%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
23.79%
5Y equity/share CAGR at 50-75% of ADI's 34.01%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
34.09%
3Y equity/share CAGR at 50-75% of ADI's 56.42%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
776.07%
Dividend/share CAGR of 776.07% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
324.16%
5Y dividend/share CAGR above 1.5x ADI's 54.63%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
54.27%
3Y dividend/share CAGR above 1.5x ADI's 24.95%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-4.34%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.64%
Inventory growth well above ADI's 0.70%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.38%
Negative asset growth while ADI invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.47%
Under 50% of ADI's 1.24%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-5.49%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
7.38%
R&D growth drastically higher vs. ADI's 0.39%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
4.05%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.